US 11654199
Thienoazepine immunoconjugates, and uses thereof
granted A61KA61K47/6803A61K47/6849
Quick answer
US patent 11654199 (Thienoazepine immunoconjugates, and uses thereof) held by Bolt Biotherapeutics, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bolt Biotherapeutics, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K47/6803, A61K47/6849, A61K47/6855, A61K47/6889